INDEPENDENT DIRECTOR AGREEMENTIndependent Director Agreement • August 16th, 2010 • Huifeng Bio-Pharmaceutical Technology, Inc. • Medicinal chemicals & botanical products • Nevada
THIS INDEPENDENT DIRECTOR AGREEMENT (“Agreement”) is made effective as of May 8, 2010 by and between HUIFENG BIO-PHARMACEUTICAL TECHNOLOGY, INC., a Nevada Corporation (“Company”), and LUI CHI KEUNG (“Director”).
SETTLEMENT AGREEMENT AND RELEASESettlement Agreement and Release • August 16th, 2010 • Huifeng Bio-Pharmaceutical Technology, Inc. • Medicinal chemicals & botanical products • New York
This Settlement Agreement and Release (“Agreement”) is entered into this 30th day of June, 2010 (the “Effective Date”) by and among HUIFENG BIO-PHARMACEUTICAL TECHNOLOGY, INC. (the “Company”), Jing An Wang (“Wang”), PROFESSIONAL OFFSHORE OPPORTUNITY FUND, LTD. (“PROOF”), Peter Treadway, Janet Wang, Manilal Patel, ANCORA GREATER CHINA FUND (“ANCORA”), STRATEGIC ALLIANCE FUND, L.P. (“STRATEGIC ALLIANCE”), STRATEGIC ALLIANCE FUND II, L.P. (together with PROOF, Peter Treadway, Janet Wang, Manilal Patel, ANCORA and STRATEGIC ALLIANCE, the “Buyers”) and Sullivan & Worcester LLP (the “Escrow Agent”). The Company, Wang and the Buyers will sometimes be referred to collectively in this Agreement as the “Parties.”
